NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc.("Replimune" or the "Company") (NASDAQ:REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]

NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ:RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Flywire Corporation ("Flywire" or the "Company") (NASDAQ:FLYW) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-04110, is

NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE:BHVN) and certain officers. The class action, filed in the United States District Court for the District of Connecticut, and docketed under 25-cv-01120, is on

NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ:WOOF) and certain officers. The class action, filed in the United States District Court for the Southern District of California, and

NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The J.M. Smucker Company ("Smucker" or the "Company") (NYSE:SJM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers

Washington, D.C., Aug. 23, 2025 (GLOBE NEWSWIRE) — For years, Elon Musk has warned of the dangers of unchecked AI while simultaneously pursuing the technology's most ambitious applications. Now, his plans have taken physical form. According to the report: “Right here, at a remote warehouse in Memphis, TN… Elon Musk has created the AI mothership…”

Elon Musk's AI “Mothership” Could Launch the Next Wave of Superintelligence In a newly released presentation, James Altucher unveils Musk's colossal AI project — the so-called “mothership” — and why it may redefine the future of technology. GlobeNewswire August 23, 2025 Washington, D.C., Aug. 23, 2025 (GLOBE NEWSWIRE) — For years, Elon Musk has warned

(NYSE:HIMS), SAN DIEGO, Aug. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the “Class Period”), have until this upcoming Monday, August 25, 2025

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – HIMS GlobeNewswire August 23, 2025 SAN DIEGO, Aug. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or